This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Technology / Ireland INSPIRE Prostate Cancer Trial
Tech medical trial

Ireland INSPIRE Prostate Cancer Trial

Analysis based on 7 articles · First reported Apr 22, 2026 · Last updated Apr 22, 2026

Sentiment
40
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The INSPIRE study, funded by Teleflex and sponsored by Cancer Trials Ireland, could lead to improved prostate cancer treatments, potentially benefiting Teleflex's medical device market and enhancing Republic of Ireland's reputation in medical research. This development could positively impact the healthcare and biotechnology sectors by offering more effective and less burdensome treatment options.

Healthcare Biotechnology
Event Summary

A new radiotherapy clinical trial, the INSPIRE study, is set to recruit 136 patients across Republic of Ireland over the next two years. The study, co-chief investigated by Suneil Jain from Queen s University Belfast, aims to reduce side-effects of prostate cancer treatment using a 'second-generation' stereotactic ablative radiotherapy (SABR) approach combined with a protective gel spacer. This innovative method seeks to increase radiation dose to the tumor while minimizing impact on healthy tissues. The INSPIRE study is sponsored by Cancer Trials Ireland, funded by Teleflex, and supported by the Irish Research Radiation Oncology Group, representing a significant collaborative effort to improve quality of life for men diagnosed with prostate cancer in Republic of Ireland.

Entities Involved
stock
Teleflex
Teleflex is funding the INSPIRE study, which aims to improve prostate cancer treatment, potentially increasing its market presence in medical devices.
Importance 70.0 Sentiment 20.0
ngo
Cancer Trials Ireland
Cancer Trials Ireland is sponsoring the INSPIRE study, playing a crucial role in facilitating the clinical trial for prostate cancer treatment.
Importance 70.0 Sentiment 10.0
ngo
Irish Research Radiation Oncology Group
The Irish Research Radiation Oncology Group is supporting the INSPIRE study, contributing to the collaborative effort to advance prostate cancer radiotherapy.
Importance 60.0 Sentiment 10.0
per
Suneil Jain
Suneil Jain is a co-chief investigator of the INSPIRE study, leading the research efforts to improve prostate cancer treatment.
Importance 50.0 Sentiment 10.0
cnt
Republic of Ireland
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.